nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—multiple sclerosis	0.801	1	CbGaD
Misoprostol—Dinoprostone—PTGER4—multiple sclerosis	0.00243	1	CrCbGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000266	0.00245	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—RGS1—multiple sclerosis	0.000263	0.00242	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCR2—multiple sclerosis	0.00026	0.00239	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000259	0.00238	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000259	0.00238	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000257	0.00236	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000254	0.00234	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—GPR65—multiple sclerosis	0.000249	0.0023	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000244	0.00225	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CNR1—multiple sclerosis	0.00024	0.00221	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—RGS1—multiple sclerosis	0.000239	0.0022	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000239	0.0022	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL3—multiple sclerosis	0.000236	0.00217	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000234	0.00216	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000233	0.00215	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000233	0.00214	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000231	0.00212	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000228	0.0021	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CCR1—multiple sclerosis	0.000228	0.0021	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000227	0.00209	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—GPR65—multiple sclerosis	0.000226	0.00208	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00022	0.00203	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000219	0.00202	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LINGO1—multiple sclerosis	0.000219	0.00202	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL3—multiple sclerosis	0.000218	0.00201	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCL10—multiple sclerosis	0.000216	0.00199	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—RGS1—multiple sclerosis	0.000216	0.00199	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000215	0.00198	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCR2—multiple sclerosis	0.000213	0.00197	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—S1PR1—multiple sclerosis	0.000213	0.00196	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000211	0.00194	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—PTGER4—multiple sclerosis	0.00021	0.00193	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00021	0.00193	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCR1—multiple sclerosis	0.000207	0.00191	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCL13—multiple sclerosis	0.000207	0.00191	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000205	0.00189	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCR3—multiple sclerosis	0.000202	0.00187	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0002	0.00185	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—RGS1—multiple sclerosis	0.000199	0.00184	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCR2—multiple sclerosis	0.000197	0.00181	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CNR1—multiple sclerosis	0.000197	0.00181	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—RGS1—multiple sclerosis	0.000196	0.00181	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000195	0.00179	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TAGAP—multiple sclerosis	0.00019	0.00175	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GPR65—multiple sclerosis	0.000189	0.00174	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000187	0.00172	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000187	0.00172	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCL5—multiple sclerosis	0.000186	0.00171	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GPR65—multiple sclerosis	0.000186	0.00171	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000185	0.0017	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CNR1—multiple sclerosis	0.000182	0.00167	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—RGS1—multiple sclerosis	0.000181	0.00167	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000181	0.00166	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LINGO1—multiple sclerosis	0.00018	0.00166	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000177	0.00163	CbGpPWpGaD
Misoprostol—Shock—Mitoxantrone—multiple sclerosis	0.000173	0.00197	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCR1—multiple sclerosis	0.000173	0.00159	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000173	0.00159	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000173	0.00196	CcSEcCtD
Misoprostol—Body temperature increased—Azathioprine—multiple sclerosis	0.000172	0.00196	CcSEcCtD
Misoprostol—Abdominal pain—Azathioprine—multiple sclerosis	0.000172	0.00196	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000172	0.00158	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GPR65—multiple sclerosis	0.000171	0.00158	CbGpPWpGaD
Misoprostol—Vomiting—Cladribine—multiple sclerosis	0.00017	0.00194	CcSEcCtD
Misoprostol—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00017	0.00194	CcSEcCtD
Misoprostol—Erectile dysfunction—Prednisone—multiple sclerosis	0.00017	0.00193	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CCR1—multiple sclerosis	0.00017	0.00157	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00017	0.00157	CbGpPWpGaD
Misoprostol—Rash—Cladribine—multiple sclerosis	0.000169	0.00192	CcSEcCtD
Misoprostol—Dermatitis—Cladribine—multiple sclerosis	0.000169	0.00192	CcSEcCtD
Misoprostol—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000169	0.00192	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000168	0.00155	CbGpPWpGaD
Misoprostol—Headache—Cladribine—multiple sclerosis	0.000168	0.00191	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CCR5—multiple sclerosis	0.000167	0.00154	CbGpPWpGaD
Misoprostol—Arrhythmia—Triamcinolone—multiple sclerosis	0.000167	0.0019	CcSEcCtD
Misoprostol—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000167	0.0019	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000167	0.00154	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—S1PR1—multiple sclerosis	0.000166	0.00153	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LINGO1—multiple sclerosis	0.000166	0.00153	CbGpPWpGaD
Misoprostol—Hypotension—Mitoxantrone—multiple sclerosis	0.000165	0.00187	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—POMC—multiple sclerosis	0.000164	0.00151	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCL10—multiple sclerosis	0.000164	0.00151	CbGpPWpGaD
Misoprostol—Visual impairment—Betamethasone—multiple sclerosis	0.000164	0.00186	CcSEcCtD
Misoprostol—Visual impairment—Dexamethasone—multiple sclerosis	0.000164	0.00186	CcSEcCtD
Misoprostol—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000162	0.00185	CcSEcCtD
Misoprostol—Myocardial infarction—Prednisone—multiple sclerosis	0.000161	0.00184	CcSEcCtD
Misoprostol—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000161	0.00184	CcSEcCtD
Misoprostol—Breast disorder—Methotrexate—multiple sclerosis	0.000161	0.00184	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—GPC5—multiple sclerosis	0.000161	0.00149	CbGpPWpGaD
Misoprostol—Hypersensitivity—Azathioprine—multiple sclerosis	0.000161	0.00183	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000161	0.00183	CcSEcCtD
Misoprostol—Nausea—Cladribine—multiple sclerosis	0.000159	0.00181	CcSEcCtD
Misoprostol—Syncope—Prednisolone—multiple sclerosis	0.000159	0.00181	CcSEcCtD
Misoprostol—Back pain—Triamcinolone—multiple sclerosis	0.000158	0.00179	CcSEcCtD
Misoprostol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000157	0.00179	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCR1—multiple sclerosis	0.000157	0.00144	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL13—multiple sclerosis	0.000157	0.00144	CbGpPWpGaD
Misoprostol—Somnolence—Mitoxantrone—multiple sclerosis	0.000157	0.00178	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TAGAP—multiple sclerosis	0.000156	0.00144	CbGpPWpGaD
Misoprostol—Loss of consciousness—Prednisolone—multiple sclerosis	0.000156	0.00177	CcSEcCtD
Misoprostol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000155	0.00176	CcSEcCtD
Misoprostol—Hypertension—Prednisolone—multiple sclerosis	0.000153	0.00174	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CCL5—multiple sclerosis	0.000153	0.00141	CbGpPWpGaD
Misoprostol—Fatigue—Mitoxantrone—multiple sclerosis	0.000152	0.00173	CcSEcCtD
Misoprostol—Arrhythmia—Betamethasone—multiple sclerosis	0.000152	0.00172	CcSEcCtD
Misoprostol—Arrhythmia—Dexamethasone—multiple sclerosis	0.000152	0.00172	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000151	0.00139	CbGpPWpGaD
Misoprostol—Pain—Mitoxantrone—multiple sclerosis	0.000151	0.00171	CcSEcCtD
Misoprostol—Constipation—Mitoxantrone—multiple sclerosis	0.000151	0.00171	CcSEcCtD
Misoprostol—Alopecia—Dexamethasone—multiple sclerosis	0.00015	0.00171	CcSEcCtD
Misoprostol—Alopecia—Betamethasone—multiple sclerosis	0.00015	0.00171	CcSEcCtD
Misoprostol—Diarrhoea—Azathioprine—multiple sclerosis	0.000149	0.0017	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCL3—multiple sclerosis	0.000147	0.00136	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CCR2—multiple sclerosis	0.000147	0.00135	CbGpPWpGaD
Misoprostol—Syncope—Triamcinolone—multiple sclerosis	0.000146	0.00166	CcSEcCtD
Misoprostol—Syncope—Methylprednisolone—multiple sclerosis	0.000146	0.00166	CcSEcCtD
Misoprostol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000145	0.00165	CcSEcCtD
Misoprostol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000145	0.00164	CcSEcCtD
Misoprostol—Oedema—Prednisolone—multiple sclerosis	0.000145	0.00164	CcSEcCtD
Misoprostol—Dysuria—Methotrexate—multiple sclerosis	0.000144	0.00164	CcSEcCtD
Misoprostol—Dizziness—Azathioprine—multiple sclerosis	0.000144	0.00164	CcSEcCtD
Misoprostol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000144	0.00164	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—TAGAP—multiple sclerosis	0.000144	0.00132	CbGpPWpGaD
Misoprostol—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000143	0.00163	CcSEcCtD
Misoprostol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000143	0.00163	CcSEcCtD
Misoprostol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000143	0.00162	CcSEcCtD
Misoprostol—Shock—Prednisolone—multiple sclerosis	0.000142	0.00162	CcSEcCtD
Misoprostol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000142	0.00162	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000141	0.0013	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RGS1—multiple sclerosis	0.000141	0.0013	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL5—multiple sclerosis	0.000141	0.0013	CbGpPWpGaD
Misoprostol—Hypertension—Triamcinolone—multiple sclerosis	0.000141	0.0016	CcSEcCtD
Misoprostol—Hypertension—Methylprednisolone—multiple sclerosis	0.00014	0.0016	CcSEcCtD
Misoprostol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00014	0.00159	CcSEcCtD
Misoprostol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000139	0.00158	CcSEcCtD
Misoprostol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000139	0.00158	CcSEcCtD
Misoprostol—Myalgia—Triamcinolone—multiple sclerosis	0.000139	0.00158	CcSEcCtD
Misoprostol—Vomiting—Azathioprine—multiple sclerosis	0.000139	0.00158	CcSEcCtD
Misoprostol—Pneumonia—Methotrexate—multiple sclerosis	0.000138	0.00157	CcSEcCtD
Misoprostol—Arthralgia—Methylprednisolone—multiple sclerosis	0.000138	0.00157	CcSEcCtD
Misoprostol—Myalgia—Methylprednisolone—multiple sclerosis	0.000138	0.00157	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000138	0.00127	CbGpPWpGaD
Misoprostol—Anxiety—Methylprednisolone—multiple sclerosis	0.000138	0.00157	CcSEcCtD
Misoprostol—Drowsiness—Methotrexate—multiple sclerosis	0.000138	0.00156	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CCR5—multiple sclerosis	0.000138	0.00127	CbGpPWpGaD
Misoprostol—Rash—Azathioprine—multiple sclerosis	0.000137	0.00156	CcSEcCtD
Misoprostol—Dermatitis—Azathioprine—multiple sclerosis	0.000137	0.00156	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CXCR3—multiple sclerosis	0.000137	0.00126	CbGpPWpGaD
Misoprostol—Headache—Azathioprine—multiple sclerosis	0.000137	0.00155	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—S1PR1—multiple sclerosis	0.000136	0.00125	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CNR1—multiple sclerosis	0.000136	0.00125	CbGpPWpGaD
Misoprostol—Conjunctivitis—Methotrexate—multiple sclerosis	0.000134	0.00152	CcSEcCtD
Misoprostol—Confusional state—Methylprednisolone—multiple sclerosis	0.000134	0.00152	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—GPR65—multiple sclerosis	0.000134	0.00123	CbGpPWpGaD
Misoprostol—Immune system disorder—Prednisone—multiple sclerosis	0.000134	0.00152	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCR2—multiple sclerosis	0.000133	0.00123	CbGpPWpGaD
Misoprostol—Oedema—Triamcinolone—multiple sclerosis	0.000133	0.00151	CcSEcCtD
Misoprostol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000133	0.00151	CcSEcCtD
Misoprostol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000133	0.00151	CcSEcCtD
Misoprostol—Syncope—Dexamethasone—multiple sclerosis	0.000133	0.00151	CcSEcCtD
Misoprostol—Syncope—Betamethasone—multiple sclerosis	0.000133	0.00151	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—GPC5—multiple sclerosis	0.000132	0.00122	CbGpPWpGaD
Misoprostol—Arrhythmia—Prednisone—multiple sclerosis	0.000132	0.0015	CcSEcCtD
Misoprostol—Infection—Triamcinolone—multiple sclerosis	0.000132	0.0015	CcSEcCtD
Misoprostol—Infection—Methylprednisolone—multiple sclerosis	0.000132	0.0015	CcSEcCtD
Misoprostol—Haematuria—Methotrexate—multiple sclerosis	0.000131	0.00149	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—POMC—multiple sclerosis	0.000131	0.00121	CbGpPWpGaD
Misoprostol—Shock—Triamcinolone—multiple sclerosis	0.000131	0.00149	CcSEcCtD
Misoprostol—Alopecia—Prednisone—multiple sclerosis	0.000131	0.00149	CcSEcCtD
Misoprostol—Shock—Methylprednisolone—multiple sclerosis	0.000131	0.00148	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00013	0.0012	CbGpPWpGaD
Misoprostol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00013	0.00148	CcSEcCtD
Misoprostol—Loss of consciousness—Betamethasone—multiple sclerosis	0.00013	0.00148	CcSEcCtD
Misoprostol—Epistaxis—Methotrexate—multiple sclerosis	0.00013	0.00148	CcSEcCtD
Misoprostol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00013	0.00148	CcSEcCtD
Misoprostol—Nausea—Azathioprine—multiple sclerosis	0.000129	0.00147	CcSEcCtD
Misoprostol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000129	0.00146	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000128	0.00118	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000128	0.00146	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CCL2—multiple sclerosis	0.000128	0.00118	CbGpPWpGaD
Misoprostol—Hypertension—Betamethasone—multiple sclerosis	0.000128	0.00145	CcSEcCtD
Misoprostol—Hypertension—Dexamethasone—multiple sclerosis	0.000128	0.00145	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000127	0.00117	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCR5—multiple sclerosis	0.000127	0.00117	CbGpPWpGaD
Misoprostol—Asthenia—Mitoxantrone—multiple sclerosis	0.000126	0.00144	CcSEcCtD
Misoprostol—Myalgia—Betamethasone—multiple sclerosis	0.000126	0.00143	CcSEcCtD
Misoprostol—Myalgia—Dexamethasone—multiple sclerosis	0.000126	0.00143	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—S1PR1—multiple sclerosis	0.000126	0.00116	CbGpPWpGaD
Misoprostol—Anxiety—Dexamethasone—multiple sclerosis	0.000125	0.00143	CcSEcCtD
Misoprostol—Anxiety—Betamethasone—multiple sclerosis	0.000125	0.00143	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000124	0.00114	CbGpPWpGaD
Misoprostol—Hypotension—Methylprednisolone—multiple sclerosis	0.000124	0.00141	CcSEcCtD
Misoprostol—Pain—Prednisolone—multiple sclerosis	0.000124	0.00141	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CNR1—multiple sclerosis	0.000123	0.00113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GPC5—multiple sclerosis	0.000122	0.00113	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCR1—multiple sclerosis	0.000122	0.00113	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL13—multiple sclerosis	0.000122	0.00113	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000122	0.00112	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000121	0.00138	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CCL3—multiple sclerosis	0.000121	0.00112	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000121	0.00137	CcSEcCtD
Misoprostol—Oedema—Betamethasone—multiple sclerosis	0.000121	0.00137	CcSEcCtD
Misoprostol—Oedema—Dexamethasone—multiple sclerosis	0.000121	0.00137	CcSEcCtD
Misoprostol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000121	0.00137	CcSEcCtD
Misoprostol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000121	0.00137	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000121	0.00111	CbGpPWpGaD
Misoprostol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000121	0.00137	CcSEcCtD
Misoprostol—Infection—Betamethasone—multiple sclerosis	0.00012	0.00136	CcSEcCtD
Misoprostol—Infection—Dexamethasone—multiple sclerosis	0.00012	0.00136	CcSEcCtD
Misoprostol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000119	0.00135	CcSEcCtD
Misoprostol—Visual impairment—Methotrexate—multiple sclerosis	0.000119	0.00135	CcSEcCtD
Misoprostol—Anaemia—Prednisone—multiple sclerosis	0.000119	0.00135	CcSEcCtD
Misoprostol—Shock—Dexamethasone—multiple sclerosis	0.000119	0.00135	CcSEcCtD
Misoprostol—Shock—Betamethasone—multiple sclerosis	0.000119	0.00135	CcSEcCtD
Misoprostol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000119	0.00135	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000118	0.00109	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000118	0.00134	CcSEcCtD
Misoprostol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000118	0.00134	CcSEcCtD
Misoprostol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000117	0.00133	CcSEcCtD
Misoprostol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000117	0.00133	CcSEcCtD
Misoprostol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000117	0.00133	CcSEcCtD
Misoprostol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000117	0.00133	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000117	0.00107	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RGS1—multiple sclerosis	0.000116	0.00107	CbGpPWpGaD
Misoprostol—Syncope—Prednisone—multiple sclerosis	0.000115	0.00131	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—multiple sclerosis	0.000115	0.00131	CcSEcCtD
Misoprostol—Fatigue—Triamcinolone—multiple sclerosis	0.000115	0.0013	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000114	0.00105	CbGpPWpGaD
Misoprostol—Fatigue—Methylprednisolone—multiple sclerosis	0.000114	0.0013	CcSEcCtD
Misoprostol—Pain—Triamcinolone—multiple sclerosis	0.000114	0.00129	CcSEcCtD
Misoprostol—Loss of consciousness—Prednisone—multiple sclerosis	0.000113	0.00129	CcSEcCtD
Misoprostol—Hypotension—Dexamethasone—multiple sclerosis	0.000113	0.00128	CcSEcCtD
Misoprostol—Hypotension—Betamethasone—multiple sclerosis	0.000113	0.00128	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000113	0.00104	CbGpPWpGaD
Misoprostol—Vomiting—Mitoxantrone—multiple sclerosis	0.000112	0.00127	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCL3—multiple sclerosis	0.000112	0.00103	CbGpPWpGaD
Misoprostol—Immune system disorder—Methotrexate—multiple sclerosis	0.000112	0.00127	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000111	0.00103	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000111	0.00103	CbGpPWpGaD
Misoprostol—Hypertension—Prednisone—multiple sclerosis	0.000111	0.00126	CcSEcCtD
Misoprostol—Rash—Mitoxantrone—multiple sclerosis	0.000111	0.00126	CcSEcCtD
Misoprostol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000111	0.00126	CcSEcCtD
Misoprostol—Chills—Methotrexate—multiple sclerosis	0.000111	0.00126	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CXCL10—multiple sclerosis	0.000111	0.00102	CbGpPWpGaD
Misoprostol—Headache—Mitoxantrone—multiple sclerosis	0.00011	0.00125	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00011	0.00125	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00011	0.00125	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—GPR65—multiple sclerosis	0.00011	0.00101	CbGpPWpGaD
Misoprostol—Arthralgia—Prednisone—multiple sclerosis	0.00011	0.00125	CcSEcCtD
Misoprostol—Myalgia—Prednisone—multiple sclerosis	0.00011	0.00125	CcSEcCtD
Misoprostol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00011	0.00125	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CCR2—multiple sclerosis	0.00011	0.00101	CbGpPWpGaD
Misoprostol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000109	0.00124	CcSEcCtD
Misoprostol—Anxiety—Prednisone—multiple sclerosis	0.000109	0.00124	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—multiple sclerosis	0.000109	0.00124	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000108	0.00123	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000108	0.000991	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—POMC—multiple sclerosis	0.000107	0.00099	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RGS1—multiple sclerosis	0.000107	0.000985	CbGpPWpGaD
Misoprostol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000107	0.00121	CcSEcCtD
Misoprostol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000106	0.00121	CcSEcCtD
Misoprostol—Dyspepsia—Betamethasone—multiple sclerosis	0.000106	0.00121	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CCL2—multiple sclerosis	0.000105	0.000969	CbGpPWpGaD
Misoprostol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000105	0.00119	CcSEcCtD
Misoprostol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000105	0.00119	CcSEcCtD
Misoprostol—Oedema—Prednisone—multiple sclerosis	0.000105	0.00119	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CCL5—multiple sclerosis	0.000105	0.000968	CbGpPWpGaD
Misoprostol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000105	0.00119	CcSEcCtD
Misoprostol—Nausea—Mitoxantrone—multiple sclerosis	0.000105	0.00119	CcSEcCtD
Misoprostol—Infection—Prednisone—multiple sclerosis	0.000104	0.00119	CcSEcCtD
Misoprostol—Back pain—Methotrexate—multiple sclerosis	0.000104	0.00118	CcSEcCtD
Misoprostol—Fatigue—Dexamethasone—multiple sclerosis	0.000104	0.00118	CcSEcCtD
Misoprostol—Fatigue—Betamethasone—multiple sclerosis	0.000104	0.00118	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000104	0.000957	CbGpPWpGaD
Misoprostol—Shock—Prednisone—multiple sclerosis	0.000103	0.00117	CcSEcCtD
Misoprostol—Pain—Betamethasone—multiple sclerosis	0.000103	0.00117	CcSEcCtD
Misoprostol—Pain—Dexamethasone—multiple sclerosis	0.000103	0.00117	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000103	0.000946	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000102	0.00115	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—GPR65—multiple sclerosis	0.000101	0.000933	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CNR1—multiple sclerosis	0.000101	0.000931	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCR2—multiple sclerosis	0.000101	0.000931	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL13—multiple sclerosis	0.0001	0.000925	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCR1—multiple sclerosis	0.0001	0.000925	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0001	0.000923	CbGpPWpGaD
Misoprostol—Anaemia—Methotrexate—multiple sclerosis	9.94e-05	0.00113	CcSEcCtD
Misoprostol—Feeling abnormal—Dexamethasone—multiple sclerosis	9.94e-05	0.00113	CcSEcCtD
Misoprostol—Feeling abnormal—Betamethasone—multiple sclerosis	9.94e-05	0.00113	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—POMC—multiple sclerosis	9.92e-05	0.000914	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.86e-05	0.00112	CcSEcCtD
Misoprostol—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.86e-05	0.00112	CcSEcCtD
Misoprostol—Hypersensitivity—Triamcinolone—multiple sclerosis	9.8e-05	0.00111	CcSEcCtD
Misoprostol—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.77e-05	0.00111	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CCL2—multiple sclerosis	9.7e-05	0.000894	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.57e-05	0.00109	CcSEcCtD
Misoprostol—Dizziness—Prednisolone—multiple sclerosis	9.56e-05	0.00109	CcSEcCtD
Misoprostol—Asthenia—Triamcinolone—multiple sclerosis	9.54e-05	0.00108	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCL5—multiple sclerosis	9.54e-05	0.000879	CbGpPWpGaD
Misoprostol—Body temperature increased—Dexamethasone—multiple sclerosis	9.54e-05	0.00108	CcSEcCtD
Misoprostol—Abdominal pain—Betamethasone—multiple sclerosis	9.54e-05	0.00108	CcSEcCtD
Misoprostol—Abdominal pain—Dexamethasone—multiple sclerosis	9.54e-05	0.00108	CcSEcCtD
Misoprostol—Body temperature increased—Betamethasone—multiple sclerosis	9.54e-05	0.00108	CcSEcCtD
Misoprostol—Asthenia—Methylprednisolone—multiple sclerosis	9.52e-05	0.00108	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CCR5—multiple sclerosis	9.46e-05	0.000872	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CNR1—multiple sclerosis	9.33e-05	0.000859	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—IL2RA—multiple sclerosis	9.33e-05	0.000859	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCR1—multiple sclerosis	9.26e-05	0.000854	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL13—multiple sclerosis	9.26e-05	0.000854	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL10—multiple sclerosis	9.25e-05	0.000852	CbGpPWpGaD
Misoprostol—Dyspepsia—Prednisone—multiple sclerosis	9.25e-05	0.00105	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—multiple sclerosis	9.16e-05	0.00104	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—multiple sclerosis	9.16e-05	0.00104	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—multiple sclerosis	9.16e-05	0.00104	CcSEcCtD
Misoprostol—Rash—Prednisolone—multiple sclerosis	9.12e-05	0.00104	CcSEcCtD
Misoprostol—Dermatitis—Prednisolone—multiple sclerosis	9.11e-05	0.00104	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CXCL10—multiple sclerosis	9.1e-05	0.000838	CbGpPWpGaD
Misoprostol—Diarrhoea—Methylprednisolone—multiple sclerosis	9.08e-05	0.00103	CcSEcCtD
Misoprostol—Fatigue—Prednisone—multiple sclerosis	9.06e-05	0.00103	CcSEcCtD
Misoprostol—Headache—Prednisolone—multiple sclerosis	9.06e-05	0.00103	CcSEcCtD
Misoprostol—Constipation—Prednisone—multiple sclerosis	8.98e-05	0.00102	CcSEcCtD
Misoprostol—Confusional state—Methotrexate—multiple sclerosis	8.85e-05	0.00101	CcSEcCtD
Misoprostol—Dizziness—Triamcinolone—multiple sclerosis	8.79e-05	0.000999	CcSEcCtD
Misoprostol—Anaphylactic shock—Methotrexate—multiple sclerosis	8.78e-05	0.000998	CcSEcCtD
Misoprostol—Dizziness—Methylprednisolone—multiple sclerosis	8.77e-05	0.000997	CcSEcCtD
Misoprostol—Infection—Methotrexate—multiple sclerosis	8.72e-05	0.000992	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CCL3—multiple sclerosis	8.71e-05	0.000803	CbGpPWpGaD
Misoprostol—Feeling abnormal—Prednisone—multiple sclerosis	8.66e-05	0.000984	CcSEcCtD
Misoprostol—Asthenia—Betamethasone—multiple sclerosis	8.66e-05	0.000984	CcSEcCtD
Misoprostol—Asthenia—Dexamethasone—multiple sclerosis	8.66e-05	0.000984	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CCL5—multiple sclerosis	8.63e-05	0.000795	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Methotrexate—multiple sclerosis	8.6e-05	0.000977	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCR5—multiple sclerosis	8.59e-05	0.000792	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Prednisone—multiple sclerosis	8.59e-05	0.000977	CcSEcCtD
Misoprostol—Nausea—Prednisolone—multiple sclerosis	8.59e-05	0.000976	CcSEcCtD
Misoprostol—Hyperhidrosis—Methotrexate—multiple sclerosis	8.49e-05	0.000965	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—IL2RA—multiple sclerosis	8.47e-05	0.00078	CbGpPWpGaD
Misoprostol—Vomiting—Triamcinolone—multiple sclerosis	8.45e-05	0.000961	CcSEcCtD
Misoprostol—Vomiting—Methylprednisolone—multiple sclerosis	8.43e-05	0.000959	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CXCL10—multiple sclerosis	8.4e-05	0.000774	CbGpPWpGaD
Misoprostol—Rash—Triamcinolone—multiple sclerosis	8.38e-05	0.000953	CcSEcCtD
Misoprostol—Dermatitis—Triamcinolone—multiple sclerosis	8.37e-05	0.000952	CcSEcCtD
Misoprostol—Rash—Methylprednisolone—multiple sclerosis	8.36e-05	0.000951	CcSEcCtD
Misoprostol—Dermatitis—Methylprednisolone—multiple sclerosis	8.36e-05	0.00095	CcSEcCtD
Misoprostol—Headache—Triamcinolone—multiple sclerosis	8.33e-05	0.000947	CcSEcCtD
Misoprostol—Headache—Methylprednisolone—multiple sclerosis	8.31e-05	0.000945	CcSEcCtD
Misoprostol—Body temperature increased—Prednisone—multiple sclerosis	8.3e-05	0.000944	CcSEcCtD
Misoprostol—Abdominal pain—Prednisone—multiple sclerosis	8.3e-05	0.000944	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PGR—multiple sclerosis	8.26e-05	0.000761	CbGpPWpGaD
Misoprostol—Diarrhoea—Dexamethasone—multiple sclerosis	8.25e-05	0.000938	CcSEcCtD
Misoprostol—Diarrhoea—Betamethasone—multiple sclerosis	8.25e-05	0.000938	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—multiple sclerosis	8.2e-05	0.000933	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CXCR3—multiple sclerosis	8.1e-05	0.000746	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CD28—multiple sclerosis	8.02e-05	0.000739	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8e-05	0.000909	CcSEcCtD
Misoprostol—Dizziness—Dexamethasone—multiple sclerosis	7.98e-05	0.000907	CcSEcCtD
Misoprostol—Dizziness—Betamethasone—multiple sclerosis	7.98e-05	0.000907	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCL5—multiple sclerosis	7.96e-05	0.000733	CbGpPWpGaD
Misoprostol—Nausea—Triamcinolone—multiple sclerosis	7.9e-05	0.000898	CcSEcCtD
Misoprostol—Nausea—Methylprednisolone—multiple sclerosis	7.88e-05	0.000896	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CCR2—multiple sclerosis	7.88e-05	0.000726	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL5—multiple sclerosis	7.83e-05	0.000722	CbGpPWpGaD
Misoprostol—Dyspnoea—Methotrexate—multiple sclerosis	7.83e-05	0.00089	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—multiple sclerosis	7.81e-05	0.000887	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CCR5—multiple sclerosis	7.77e-05	0.000716	CbGpPWpGaD
Misoprostol—Hypersensitivity—Prednisone—multiple sclerosis	7.74e-05	0.00088	CcSEcCtD
Misoprostol—Dyspepsia—Methotrexate—multiple sclerosis	7.73e-05	0.000879	CcSEcCtD
Misoprostol—Vomiting—Betamethasone—multiple sclerosis	7.67e-05	0.000872	CcSEcCtD
Misoprostol—Vomiting—Dexamethasone—multiple sclerosis	7.67e-05	0.000872	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—IL2RA—multiple sclerosis	7.66e-05	0.000706	CbGpPWpGaD
Misoprostol—Rash—Betamethasone—multiple sclerosis	7.61e-05	0.000865	CcSEcCtD
Misoprostol—Rash—Dexamethasone—multiple sclerosis	7.61e-05	0.000865	CcSEcCtD
Misoprostol—Dermatitis—Dexamethasone—multiple sclerosis	7.6e-05	0.000864	CcSEcCtD
Misoprostol—Dermatitis—Betamethasone—multiple sclerosis	7.6e-05	0.000864	CcSEcCtD
Misoprostol—Fatigue—Methotrexate—multiple sclerosis	7.57e-05	0.00086	CcSEcCtD
Misoprostol—Headache—Betamethasone—multiple sclerosis	7.56e-05	0.000859	CcSEcCtD
Misoprostol—Headache—Dexamethasone—multiple sclerosis	7.56e-05	0.000859	CcSEcCtD
Misoprostol—Asthenia—Prednisone—multiple sclerosis	7.54e-05	0.000857	CcSEcCtD
Misoprostol—Pain—Methotrexate—multiple sclerosis	7.51e-05	0.000853	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—POMC—multiple sclerosis	7.4e-05	0.000681	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CNR1—multiple sclerosis	7.27e-05	0.00067	CbGpPWpGaD
Misoprostol—Feeling abnormal—Methotrexate—multiple sclerosis	7.23e-05	0.000822	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCL5—multiple sclerosis	7.23e-05	0.000666	CbGpPWpGaD
Misoprostol—Diarrhoea—Prednisone—multiple sclerosis	7.19e-05	0.000817	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.18e-05	0.000816	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCR5—multiple sclerosis	7.17e-05	0.000661	CbGpPWpGaD
Misoprostol—Nausea—Dexamethasone—multiple sclerosis	7.17e-05	0.000815	CcSEcCtD
Misoprostol—Nausea—Betamethasone—multiple sclerosis	7.17e-05	0.000815	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CCL3—multiple sclerosis	7.15e-05	0.000659	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2RA—multiple sclerosis	7.07e-05	0.000651	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCR5—multiple sclerosis	7.06e-05	0.00065	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2RA—multiple sclerosis	6.95e-05	0.000641	CbGpPWpGaD
Misoprostol—Dizziness—Prednisone—multiple sclerosis	6.95e-05	0.00079	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—multiple sclerosis	6.94e-05	0.000789	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—multiple sclerosis	6.94e-05	0.000789	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PTGER4—multiple sclerosis	6.89e-05	0.000634	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PGR—multiple sclerosis	6.78e-05	0.000625	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—POMC—multiple sclerosis	6.72e-05	0.000619	CbGpPWpGaD
Misoprostol—Vomiting—Prednisone—multiple sclerosis	6.68e-05	0.000759	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CXCR3—multiple sclerosis	6.65e-05	0.000613	CbGpPWpGaD
Misoprostol—Rash—Prednisone—multiple sclerosis	6.62e-05	0.000753	CcSEcCtD
Misoprostol—Dermatitis—Prednisone—multiple sclerosis	6.62e-05	0.000752	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCL3—multiple sclerosis	6.6e-05	0.000608	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CD28—multiple sclerosis	6.59e-05	0.000607	CbGpPWpGaD
Misoprostol—Headache—Prednisone—multiple sclerosis	6.58e-05	0.000748	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCL2—multiple sclerosis	6.57e-05	0.000605	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL10—multiple sclerosis	6.55e-05	0.000603	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCR5—multiple sclerosis	6.51e-05	0.0006	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCR2—multiple sclerosis	6.47e-05	0.000596	CbGpPWpGaD
Misoprostol—Hypersensitivity—Methotrexate—multiple sclerosis	6.47e-05	0.000735	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—IL2RA—multiple sclerosis	6.42e-05	0.000591	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTGER4—multiple sclerosis	6.35e-05	0.000585	CbGpPWpGaD
Misoprostol—Asthenia—Methotrexate—multiple sclerosis	6.3e-05	0.000716	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PGR—multiple sclerosis	6.26e-05	0.000577	CbGpPWpGaD
Misoprostol—Nausea—Prednisone—multiple sclerosis	6.24e-05	0.000709	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CXCR3—multiple sclerosis	6.14e-05	0.000565	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CD28—multiple sclerosis	6.08e-05	0.00056	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—POMC—multiple sclerosis	6.07e-05	0.00056	CbGpPWpGaD
Misoprostol—Diarrhoea—Methotrexate—multiple sclerosis	6.01e-05	0.000683	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCR2—multiple sclerosis	5.97e-05	0.00055	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CNR1—multiple sclerosis	5.97e-05	0.00055	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—TYK2—multiple sclerosis	5.97e-05	0.00055	CbGpPWpGaD
Misoprostol—Dizziness—Methotrexate—multiple sclerosis	5.81e-05	0.00066	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CD86—multiple sclerosis	5.72e-05	0.000527	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL5—multiple sclerosis	5.63e-05	0.000519	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—POMC—multiple sclerosis	5.6e-05	0.000516	CbGpPWpGaD
Misoprostol—Vomiting—Methotrexate—multiple sclerosis	5.58e-05	0.000635	CcSEcCtD
Misoprostol—Rash—Methotrexate—multiple sclerosis	5.54e-05	0.000629	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—multiple sclerosis	5.53e-05	0.000629	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—POMC—multiple sclerosis	5.52e-05	0.000508	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CNR1—multiple sclerosis	5.51e-05	0.000508	CbGpPWpGaD
Misoprostol—Headache—Methotrexate—multiple sclerosis	5.5e-05	0.000625	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—IL2—multiple sclerosis	5.47e-05	0.000504	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL2—multiple sclerosis	5.4e-05	0.000497	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL10—multiple sclerosis	5.38e-05	0.000495	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SPP1—multiple sclerosis	5.22e-05	0.000481	CbGpPWpGaD
Misoprostol—Nausea—Methotrexate—multiple sclerosis	5.22e-05	0.000593	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—POMC—multiple sclerosis	5.09e-05	0.000469	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCR5—multiple sclerosis	5.08e-05	0.000468	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2RA—multiple sclerosis	5e-05	0.000461	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL2—multiple sclerosis	4.98e-05	0.000459	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL2—multiple sclerosis	4.97e-05	0.000457	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL10—multiple sclerosis	4.96e-05	0.000457	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—TYK2—multiple sclerosis	4.9e-05	0.000451	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CD86—multiple sclerosis	4.7e-05	0.000433	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL5—multiple sclerosis	4.63e-05	0.000426	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APOE—multiple sclerosis	4.62e-05	0.000426	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—TYK2—multiple sclerosis	4.52e-05	0.000417	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—multiple sclerosis	4.49e-05	0.000414	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CD86—multiple sclerosis	4.34e-05	0.0004	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SPP1—multiple sclerosis	4.29e-05	0.000395	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL5—multiple sclerosis	4.27e-05	0.000393	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CD80—multiple sclerosis	4.18e-05	0.000385	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCR5—multiple sclerosis	4.17e-05	0.000384	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—multiple sclerosis	4.14e-05	0.000382	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2RA—multiple sclerosis	4.11e-05	0.000379	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—multiple sclerosis	4.08e-05	0.000376	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—POMC—multiple sclerosis	3.97e-05	0.000366	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SPP1—multiple sclerosis	3.95e-05	0.000364	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL2—multiple sclerosis	3.88e-05	0.000358	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCR5—multiple sclerosis	3.85e-05	0.000354	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—MAPK1—multiple sclerosis	3.8e-05	0.00035	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APOE—multiple sclerosis	3.79e-05	0.000349	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2RA—multiple sclerosis	3.79e-05	0.000349	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—multiple sclerosis	3.76e-05	0.000347	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TYK2—multiple sclerosis	3.52e-05	0.000325	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APOE—multiple sclerosis	3.5e-05	0.000322	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CD80—multiple sclerosis	3.43e-05	0.000316	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—POMC—multiple sclerosis	3.26e-05	0.0003	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL2—multiple sclerosis	3.19e-05	0.000294	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CD80—multiple sclerosis	3.16e-05	0.000292	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MAPK1—multiple sclerosis	3.12e-05	0.000287	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—POMC—multiple sclerosis	3.01e-05	0.000277	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL2—multiple sclerosis	2.94e-05	0.000271	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—multiple sclerosis	2.93e-05	0.00027	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—multiple sclerosis	2.92e-05	0.000269	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TYK2—multiple sclerosis	2.89e-05	0.000267	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MAPK1—multiple sclerosis	2.88e-05	0.000265	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—multiple sclerosis	2.78e-05	0.000256	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TYK2—multiple sclerosis	2.67e-05	0.000246	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—multiple sclerosis	2.47e-05	0.000227	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—multiple sclerosis	2.41e-05	0.000222	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—multiple sclerosis	2.4e-05	0.000221	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—multiple sclerosis	2.29e-05	0.000211	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—multiple sclerosis	2.29e-05	0.000211	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—multiple sclerosis	2.28e-05	0.00021	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK1—multiple sclerosis	2.24e-05	0.000207	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—multiple sclerosis	2.22e-05	0.000205	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—multiple sclerosis	2.21e-05	0.000204	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—multiple sclerosis	2.1e-05	0.000194	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—multiple sclerosis	2.03e-05	0.000187	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—multiple sclerosis	1.88e-05	0.000174	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—multiple sclerosis	1.88e-05	0.000173	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—multiple sclerosis	1.87e-05	0.000172	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK1—multiple sclerosis	1.84e-05	0.00017	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—multiple sclerosis	1.74e-05	0.00016	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—multiple sclerosis	1.73e-05	0.00016	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—multiple sclerosis	1.72e-05	0.000159	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK1—multiple sclerosis	1.7e-05	0.000157	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—multiple sclerosis	1.42e-05	0.00013	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—multiple sclerosis	1.31e-05	0.00012	CbGpPWpGaD
